Ebola vaccine: preliminary efficacy results

• Univadis Medical News
• 17 April 2019

The rVSV-ZEBOV-GP Ebola vaccine is being used in a ring vaccination strategy in the Democratic Republic of the Congo.

EMA advises restricted use of MS drug alemtuzumab

• Univadis Medical News
• 17 April 2019

Healthcare professionals should consider stopping treatment in patients who develop signs of certain conditions–new recommendations.

Health professions alliance condemns new Brunei laws

• Univadis Medical News
• 17 April 2019

The World Medical Association says even advising or preparing for some of the punishments would constitute a gross violation of medical ethics.

ELCC 2019 - In first-line nonsquamous NSCLC, patients with EGFR mutations benefit from adding atezolizumab to standard care

• Oncology Conference reports
• 14 April 2019

Exploratory subgroup analysis of IMpower150 trial indicates efficacy for EGFR-mt+ patients given atezolizumab in addition to bevacizumab and standard chemotherapy

ELCC 2019 - Is there a role for gut microbiome in clinical responses to lung cancer immunotherapy?

• Oncology Conference reports
• 14 April 2019

Keynote lecture at European Lung Cancer Conference presents arguments for exploring the influence of microbes in precision medicine

ELCC 2019 - Many problems with accessibility to lung cancer care in low and middle income EU countries

• Oncology Conference reports
• 14 April 2019

Most health care systems in the eastern part of the EU are under financed and under equipped to deal with lung cancer